Author： Gilbert P.B. Chiu Y.-L. Allen M. Lawrence D.N. Chapdu C. Israel H. Holman D. Keefer M.C. Wolff M. Frey S.E. NIAID HIV Vaccine Trials Network
Publisher： Elsevier
ISSN： 0264-410X
Source： Vaccine, Vol.21, Iss.21, 2003-06, pp. : 2933-2947
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Dilts D.A. Riesenfeld-Orn I. Fulginiti J.P. Ekwall E. Granert C. Nonenmacher J. Brey R.N. Cryz S.J. Karlsson K. Bergman K. Thompson T. Hu B. Bruckner A.H. Lindberg A.A.
Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. :
Access to resources
Recommend
A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
By Nitayaphan S. Khamboonruang C. Sirisophana N. Morgan P. Chiu J. Duliege A.-M. Chuenchitra C. Supapongse T. Rungruengthanakit K. deSouza M. Mascola J.R. Boggio K. Ratto-Kim S. Markowitz L.E. Birx D. Suriyanon V. McNeil J.G. Brown A.E. Michael R.A.
Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. :
By Ehrlich H.J. Pavlova B.G. Fritsch S. Poellabauer E.-M. Loew-Baselli A. Obermann-Slupetzky O. Maritsch F. Cil I. Dorner F. Barrett P.N.
Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. :
Some important issues in the planning of phase III HIV vaccine efficacy trials
By Boily M.-C. Masse B.R. Desai K. Alary M. Anderson R.M.
Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. :